Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Primer Autor
Yusuf, Salim
Co-autores
Khatib, Rasha
Mckee, Martin
Shannon, Harry
Chow, Clara
Rangarajan, Sumathy
Teo, Koon
Wei, Li
Mony, Prem
Mohan, Viswanathan
Gupta, Rajeev
Kumar, Rajesh
Vijayakumar, Krishnapillai
Lear, Scott A.
Diaz, Rafael
Avezum, Alvaro
Lopez-Jaramillo, Patricio
Lanas, Fernando
Yusoff, Khalid
Ismail, Noorhassim
Kazmi, Khawar
Rahman, Omar
Rosengren, Annika
Monsef, Nahed
Kelishadi, Roya
Kruger, Annamarie
Puoane, Thandi
Szuba, Andrzej
Chifamba, Jephat
Temizhan, Ahmet
Dagenais, Gilles
Gafni, Amiram
Título
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Editorial
ELSEVIER SCIENCE INC
Revista
LANCET
Lenguaje
en
Tipo de Recurso
Artículo original
doi
10.1016/S0140-6736(15)00469-9
Formato Recurso
pdf
Ubicación del archivo
Id de Web of Science
WOS:000367457300028
Título de la cita (Recomendado-único)
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Identificador del recurso (Mandatado-único)
Artículo original
Versión del recurso (Recomendado-único)
version publicada
Editorial
ELSEVIER SCIENCE INC
Revista/Libro
LANCET
Categoría WOS
Medicine, General & Internal
Idioma
en
ISSN
0140-6736
Tipo de ruta
hibrida
verde
Derechos de acceso
metadata
Referencia del Financiador (Mandatado si es aplicable-repetible)
Population Health Research Institute
Canadian Institutes of Health Research
Heart and Stroke Foundation of Ontario (Canada)
Boehringer Ingelheim (Germany)
Boehringer Ingelheim (Canada)
AstraZeneca (Canada)
Sanofi - Aventis (France)
Sanofi - Aventis (Canada)
Servier
GlaxoSmithKline (GSK)
Novartis
King Pharma
Independent University, Bangladesh
Mitra and Associates
Unilever Health Institute, Brazil
Public Health Agency of Canada
Champlain Cardiovascular Disease Prevention Network
Universidad de la Frontera
National Centre for Cardiovascular Diseases
Colciencias 6566-04-18062
Indian Council of Medical Research
Ministry of Science, Technology and Innovation of Malaysia 100-IRDC/BIOTEK 16/6/21 13/2007, 07-05-IFN-MEB010]
Ministry of Higher Education of Malaysia 600-RMI/LRGS/5/3 [2/2011]
Universiti Teknologi MARA
Universiti Kebangsaan Malaysia UKM-Hejim-Komuniti-15-2010
Occupied Palestinian territory-the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory
International Development Research Centre (IDRC), Canada
Polish Ministry of Science and Higher Education 290/W-PURE/2008/0
Wroclaw Medical University
The North-West University
SANPAD (South Africa and Netherlands Programme for Alternative Development)
National Research Foundation
Medical Research Council of South Africa
South African Sugar Association (SASA)
Faculty of Community and Health Sciences (UWC)
AFA Insurance
Swedish Council for Working Life and Social Research
Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning
Swedish Heart and Lung Foundation
Swedish Research Council
Swedish State under LakarUtbildningsAvtalet
Vastra Gotaland Region (FOUU)
Metabolic Syndrome Society
AstraZeneca, Turkey
Sanofi - Aventis, Turkey
Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai United Arab Emirates
Australian National Health and Medical Research Council Career Development Fellowship
National Heart Foundation
Formato
pdf
Página final (Recomendado-único)
69
Página de inicio (Recomendado-único)
61
Estadísticas del documento
0 visitas
Métricas externas
Altmetric
Dimensions
SCImago
SCImago Journal & Country Rank